Transplant Infectious Disease

Aims & Scope

Transplant Infectious Disease has been established as a forum for presenting the most current information on the prevention and treatment of infection complicating organ and bone marrow transplantation.

The point of view of the journal is that infection and allograft rejection (or graft-versus-host disease) are closely intertwined, and that advances in one area will have immediate consequences on the other.

The interaction of the transplant recipient with potential microbial invaders, the impact of immunosuppressive strategies on this interaction, and the effects of cytokines, growth factors, and chemokines liberated during the course of infections, rejection, or graft-versus-host disease are central to the interests and mission of this journal.

Transplant Infectious Disease is aimed at disseminating the latest information relevant to the infectious disease complications of transplantation to clinicians and scientists involved in bone marrow, kidney, liver, heart, lung, intestinal, and pancreatic transplantation.

The infectious disease consequences and concerns regarding innovative transplant strategies, from novel immunosuppressive agents to xenotransplantation, are very much a concern of this journal.

In addition, this journal feels a particular responsibility to inform primary care practitioners in the community, who increasingly are sharing the responsibility for the care of these patients, of the special considerations regarding the prevention and treatment of infection in transplant recipients.

As exemplified by the international editorial board, articles are sought throughout the world that address both general issues and those of a more restricted geographic import.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.6
2024	2.60

SJR (SCImago Journal Rank)

Year	Value
2024	0.800

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	79

Journal Rank

Year	Value
2024	6777

Journal Citation Indicator

Year	Value
2024	1430

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients

  Citation: 379

  Authors: D., J.A., D., E., C.-H., A., M., W.J., K.M., K.A.

• The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants

  Citation: 322

  Authors: A., R., R.K., D.L., M., M., R., N., M.T., A., S.M.

• European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of <scp>ECIL</scp>‐4 (2011)

  Citation: 235

  Authors: S., T., P.J., D., H.H., C., P.

• Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty‐first century

  Citation: 232

  Authors: T.J., A.H.

• Identifying the patient at risk for post‐transplant lymphoproliferative disorder

  Citation: 215

  Authors: S.M.

• Outcome of treatment of Epstein–Barr virus‐related post‐transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

  Citation: 162

  Authors: J., H., L., P.

• Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant‐Associated Infection Surveillance Network (<scp>TRANSNET</scp>)

  Citation: 156

  Authors: C.A., A.G., D.R., J.W., L., R.C., B.D., E.J., K., J.I., K.M., G.M., K.A., V.A., B.J., T.F., M.G., T.M., P.G.

• The epidemiology and outcomes of invasive <i>Candida</i> infections among organ transplant recipients in the United States: results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

  Citation: 156

  Authors: David R., Nasia, John W., Barbara, Lisa, Allison, Susan, Loreen, Carol, G. Marshall, Vicki, Thomas, Trish, Randall, Tim, Tom, Peter G.

• <i>Ex vivo</i> monitoring of human cytomegalovirus‐specific CD8+ T‐cell responses using QuantiFERON^®‐CMV

  Citation: 153

  Authors: S., C., T., R., P., M., S., A., K., S., R.

• Bacterial urinary tract infection after solid organ transplantation in the <scp>RESITRA</scp> cohort

  Citation: 150

  Authors: E., J., M., M., C., J.M., O., J., E., G., P., A., M., N., J.

---